Manifold Bio
MA - BostonBiotechnology
Focus: Manifold Bio is a Boston-based biotech company specializing in measurement-driven drug design, leveraging AI and experimental validation to accelerate oncology therapeutics. The company is publicly traded and demonstrates platform-scale capabilities in protein binder design.
Profile data last refreshed 4h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
12-1 this month
Stable — net -1 jobs in 30d
2 added, 3 removed. Backfill posture.
Should You Work at Manifold Bio?
AI assessmentManifold Bio is a high-risk, high-upside AI-first drug discovery platform company ideal for scientists seeking frontier computational oncology work, but not recommended for those prioritizing pipeline visibility or near-term clinical catalysts.
Why Work Here
- Core R&D focus: 87% of 15 open roles are in Research & Development, indicating a company built around scientific innovation rather than commercial overhead.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Manifold Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.